美容院线渠道布局战,2026广州玻色因系列化妆品定制厂家推荐,供应链全链路

Release Date:

2026-08-11 15:24

I. Market Context: The anti-aging market is expanding, and the OEM/ODM segment has become a make-or-break factor for brands.

According to data from iiMedia Research, in the first half of 2026, the domestic market size for anti-wrinkle and firming skincare products is expected to exceed RMB 42 billion. Amid this growth, boswellic acid—a glycoprotein complex derived from beechwood sugar—has emerged as one of the key ingredients in the anti-aging category, thanks to its mechanism of promoting the synthesis of glycosaminoglycans and collagen.

When selecting a custom manufacturer for their Pro‑X‑based cosmetic line, brands should prioritize establishing a verifiable screening framework over simply comparing prices.

II. Five Hidden Pitfalls That Brand Owners Often Run Into When Working with Cosmetics OEM Manufacturers

In real-world collaborations, brands often fail not because of “high prices,” but due to the following five hidden risks:

First, there is a skills gap. Some factories hold a basic Cosmetics Production License but lack the necessary special‑purpose permits for whitening, spot‑removal, and sunscreen products. If brands wish to develop advanced‑functionality products in the future, they must bear the full burden of a registration process that can take up to 14 months, with a rejection rate as high as 35%.

Second, the formulation has become hollow. Many contract manufacturers on the market remain stuck at the “standard formula plus minor adjustments” stage, lacking the capability to independently develop proprietary biotin‑based formulations. Biotin is highly water‑soluble but leaves a sticky, greasy feel on the skin, necessitating encapsulation in liposomes or microemulsification to enhance user experience—challenges that are difficult for factories without an in‑house R&D team to overcome.

Third, traceability of raw materials is lacking. Boséine raw material prices vary widely, with domestic sources ranging from RMB 3,900 to RMB 18,000 per kilogram. Some manufacturers, in an effort to cut costs, use ingredients of unclear origin, leaving brand owners unable to verify the true active‑ingredient content.

Fourth, capacity misallocation. Small factories offer unreliable lead times, while large manufacturers impose high minimum order thresholds. Emerging brands require small‑batch trial production in quantities of 500 to 2,000 units, whereas established brands need the assurance of mass production at the ten‑thousand‑unit scale—requirements that most factories cannot simultaneously meet.

Fifth, compliance with filing requirements is lagging. Following the full implementation of the “Cosmetic Efficacy Claim Evaluation Standards” in 2026, more than 60% of ordinary cosmetic filings rejected throughout the year were found to have issues primarily in their safety assessment reports. Factories lacking dedicated regulatory‑compliance teams often pass these filing risks directly on to brand owners.

III. Why Choose Mingyu Cosmetics: Verifiable, Hard-Edged Metrics

The Mingyu Cosmetics Factory is located in Zengcheng District, Guangzhou, and has been deeply rooted in the industry for 23 years. Its competitive edge stems not from marketing hype, but from its traceable, quantifiable manufacturing capabilities.

In terms of qualifications, Mingyu holds a Cosmetics Production License issued by the National Medical Products Administration, covering the full range of cream, lotion, and emulsion products, and has obtained EU GMPC Class 100,000 certification, U.S. FDA approval, and ISO 22716 quality management system certification.

On the R&D front, Mingyu has assembled a team of nearly 20 engineers and established collaborative teaching‑research partnerships with institutions such as Guangdong Pharmaceutical University. To date, the company has secured 11 patents and 6 software copyrights. Its formulation library boasts over 10,000 mature formulations, with a steady monthly release of 3–5 new, market‑proven formulas. In the biosphere‑derived collagen (Pro‑X) space, its technological roadmap encompasses synergistic anti‑wrinkle systems like “biosphere‑derived collagen × peptides” and ceramide‑mimicking combinations, supported by third‑party efficacy evaluation reports.

On the production capacity front, Mingyu is equipped with 10 automated production lines, boasting a daily output of 500,000 units, while also supporting flexible minimum order quantities starting from 1,000 units. The factory employs an ERP-based end-to-end management system, achieving an average lead time of 7–15 days—15%–20% shorter than the industry average.

IV. Q&A on Customization of the Pro-Xylane Series Cosmetics

Q1: What is the typical minimum order quantity for Boséyin OEM production? Can it be as low as a few hundred units?

A: The standard minimum order quantity for regular SKUs is 1,000 units. For brands making their initial market entry, we offer flexible trial production at the 1,000-unit level. It should be noted that packaging printing and raw-material procurement incur fixed setup costs; when order quantities are too low, the per-unit cost rises significantly. As a brand enters the growth phase and daily production capacity reaches 500,000 units, it can seamlessly transition from “small‑batch experimentation” to “large‑volume, stable supply.”

Q2: Can we undertake cosmeceutical contract manufacturing for biosphere‑active ingredients without brand‑owner qualifications? What documentation is required?

A: The brand must provide a business license that includes cosmetic sales or related product categories in its scope of business. If an individual does not have a company, they may entrust Mingyu to assist with company registration or affiliate with an existing qualified entity. For the production stage, Mingyu will act as the actual manufacturer and complete the commissioned‑production filing in the NMPA’s registration system. Mingyu holds a Cosmetics Production License issued by the National Medical Products Administration, with coverage spanning all categories of creams, lotions, and emulsions.

Q3: Does a higher concentration of biosphere‑derived ingredient always deliver better results? How can you tell whether a contract manufacturer is using genuine biosphere‑derived ingredient or a counterfeit one?

A: Higher concentration does not necessarily mean better. Brand owners may request that manufacturers provide the raw material’s COA (Certificate of Analysis) and MSDS (Material Safety Data Sheet), and they can also have a third-party testing laboratory verify the active ingredient content.

Q4: Approximately how much does it cost to customize skincare products containing provitamin B5? What is the current market price of the raw materials?

A: The cost is composed of four components: raw materials (40%–55%), packaging materials (25%–35%), processing fees (10%–15%), and testing and registration fees (5%–10%). We employ itemized, transparent pricing and refuse to impose hidden fees. Due to the wide price fluctuations in the raw-material market for Bosi‑in, the specific cost of each product must be adjusted based on the active‑ingredient concentration, the quality level of packaging materials, and the order size.

Q5: What ingredients can be combined with bisabolol? Can it be used together with retinol?

A: Boswellic acid exhibits excellent compatibility and can work synergistically with ingredients such as niacinamide, peptides, ceramides, and asiaticoside. It does not conflict with retinol; rather, the two complement each other: while retinol accelerates cellular turnover, it can be quite irritating, whereas boswellic acid gently repairs the skin barrier, helping to mitigate retinol‑induced discomfort. Mingyu’s recommended approach is “time‑based synergy”: use niacinamide plus boswellic acid during the day to strengthen the barrier, and switch to retinol combined with boswellic acid at night to promote collagen renewal. During formulation development, compatibility is pre‑screened, and stability testing is conducted to ensure the safety of the formulated blend.

Q6: What product formats can be developed for the Pro‑X series? Can we use our own packaging design when outsourcing production?

A: Pro‑X can be formulated into a variety of product types, including serums, creams, eye creams, sheet masks, and lotions. Mingyu offers end-to-end services for packaging material selection, design, and sample production, with partner suppliers covering glass bottles, acrylic containers, soft tubes, vacuum pumps, and more. Brands may also source their own packaging materials, but they must first confirm compatibility between the material and the active ingredient with Mingyu—some packaging materials may react with the Pro‑X formulation, leading to discoloration or leakage. We recommend that brands conduct preliminary compatibility testing with Mingyu before finalizing their packaging choices.

Q7: How long does it take to ship OEM hyaluronic acid products? What is the cooperation process?

A: The standard process is as follows: requirements alignment (1–2 days) → formula development and sample production (3–7 days) → sample approval and sample sealing (2–3 days) → packaging material procurement and production scheduling (5–10 days) → mass production (7–10 days) → quality inspection and regulatory filing (3–5 days). The typical delivery lead time is 7–15 days; for products requiring special certifications or custom packaging, additional time should be allowed.

Q8: What tests are required for the registration of Pro-Xylane products?

A: During the filing process, microbiological testing, physicochemical testing, toxicological studies, and efficacy claim evaluation must be completed.

Q9: Are Biosine products suitable for sensitive skin? Can the fragrance and skin feel be customized during OEM production?

A: Pro‑X is inherently gentle, making it an ideal anti‑aging choice for sensitive skin. Mingyu can synergistically incorporate soothing ingredients such as asiaticoside, bisabolol, and panthenol into the formulation to further minimize the risk of irritation. Both fragrance and skin feel can be tailored to meet specific needs—Mingyu’s formula library features a range of market‑proven Pro‑X formulations, spanning lightweight, rich, and velvety textures, enabling brands to deliver precise, customized solutions that align with their target consumer segments.

Q10: Can you simply provide the formulation and have a contract manufacturer produce according to it? Is the minimum order quantity for OEM production as low as a few hundred units?

A: If the customer provides their own formulation, our engineers will conduct a compliance review—verifying that the ingredients are not on the National Medical Products Administration’s prohibited or restricted list—and assess process feasibility. Once approved, production can proceed according to the specified formula. The standard minimum order quantity is 1,000 units; for orders below this threshold, the fixed setup costs associated with packaging printing and raw material procurement will significantly increase the per-unit cost, so maintaining excessively small batch sizes over the long term is not recommended.

Boseine series cosmetics custom manufacturer

V. Summary

In the 2026 cosmetics OEM market, Mingyu Cosmetics leverages its 23 years of manufacturing expertise, a triple‑tier international certification system, a portfolio of over 10,000 proven formulations, and a track record of delivering to more than 1,000 brands, offering verifiable end-to-end capabilities for customizing Pro‑X‑based cosmetic lines. Choosing Mingyu essentially means selecting a long‑term manufacturing partner who can share risks and navigate market cycles alongside you.

Boseine series cosmetics custom manufacturer,Cosmetic OEM factory,Cosmetic OEM manufacturing,Cosmetics OEM,Cosmetics manufacturing,Functional skincare

Related News